603 filings
Page 8 of 31
SC 13G/A
fni8ucvcw95lj z3
1 Feb 23
Denali Therapeutics / BlackRock ownership change
12:00am
SC 13G/A
pe8efka
20 Jan 23
Denali Therapeutics / BAILLIE GIFFORD & CO ownership change
10:05am
4
9kv0 ern4iblv
19 Jan 23
Denali Therapeutics / Alexander O. Schuth ownership change
5:09pm
4
b21ybbiqvpy9mflg3t
10 Jan 23
Denali Therapeutics / Carole Ho ownership change
4:51pm
4
75jbkd7fsoc8rxrx50f
9 Jan 23
Denali Therapeutics / Carole Ho ownership change
9:43pm
4
mjusg92288b5qa6fb7br
9 Jan 23
Denali Therapeutics / Steve E. Krognes ownership change
9:42pm
4
id9pz k8dkp
9 Jan 23
Denali Therapeutics / Alexander O. Schuth ownership change
9:41pm
4
yglh2g8ks1rna 6546k1
9 Jan 23
Denali Therapeutics / Ryan J. Watts ownership change
9:41pm
4/A
7ttduvg2poklyv80
9 Jan 23
Denali Therapeutics / Alexander O. Schuth ownership change
4:05pm
8-K
u5wg74
9 Jan 23
Denali Therapeutics Announces Key Anticipated 2023 Milestones for Its Therapeutic Portfolio for Neurodegeneration and Lysosomal Storage Diseases
8:08am
4
k8pv41mos
5 Jan 23
Denali Therapeutics / Carole Ho ownership change
9:08pm
4
mttukh70vz5f0
5 Jan 23
Denali Therapeutics / Alexander O. Schuth ownership change
9:07pm
4
ecmhnd
5 Jan 23
Denali Therapeutics / Ryan J. Watts ownership change
9:07pm
4
fyhvowhze8fyy2xp
28 Nov 22
Denali Therapeutics / Marc Tessier-Lavigne ownership change
7:30pm
4
zgx7q
3 Nov 22
Denali Therapeutics / Marc Tessier-Lavigne ownership change
5:37pm
8-K
gj3 7p77g5lg
3 Nov 22
Denali Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
4:05pm
8-K
0uezphb 89
20 Oct 22
Denali Therapeutics Announces Pricing of $275 Million Public Offering of Common Stock
4:58pm
424B5
hkpyvu8e7d
20 Oct 22
Prospectus supplement for primary offering
4:57pm
8-K
t105kbo
18 Oct 22
Denali Therapeutics Announces Proposed Offering of Common Stock
5:09pm